- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04294446
Post-market Study of the Biodesign Hernia Graft
Post-market Study of the Biodesign® Hernia Graft
Study Overview
Detailed Description
This multicenter, open-label, prospective clinical study will evaluate the performance of the Biodesign Hernia Graft to reinforce soft tissues during ventral hernia repair.
This post-market study will enroll up to 95 patients at up to 10 clinical sites. Each clinical site will be limited to a maximum of 50 patients to ensure a variety of patients and surgical techniques are represented. There is no minimum enrollment number per site.
This study has been designed as a multicenter, open-label, prospective study to collect data on the performance of the Biodesign Hernia Graft. The inclusion and exclusion criteria for this study have been selected based on the instructions outlined in the IFU so that the results from this study can provide data on the real-world use of the device.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Samantha Stevenson, BS
- Phone Number: 765-497-3385
- Email: sstevenson@rtix.com
Study Contact Backup
- Name: Jason Hodde, MS
- Phone Number: 765-497-3385
- Email: jhodde@rtix.com
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6Z 1Y6
- Recruiting
- St. Paul's Hospital
-
Contact:
- Jerry Liu
- Phone Number: 604-682-2344
- Email: jliu4@providencehealth.bc.ca
-
Principal Investigator:
- Manoj Raval, MD
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 2Y9
- Recruiting
- Queen Elizabeth II Hospital
-
Principal Investigator:
- Samuel Minor, MD
-
Contact:
- Lisa Julien, RN
- Phone Number: 902-473-3877
- Email: lisa.julien@nshealth.ca
-
-
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Recruiting
- Vanderbilt University Medical Center
-
Contact:
- Joan Kaiser, RN
- Phone Number: 615-343-5821
- Email: joan.l.kaiser@vumc.org
-
Principal Investigator:
- Richard Pierce, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
1. Primary or recurrent ventral hernia in need of surgical repair utilizing a Biodesign Hernia Graft
Exclusion Criteria:
Known sensitivity to porcine material
For the study, the following patients will also be excluded:
- Age < 18 years
- Unable or unwilling to provide informed consent
- Life expectancy of less than one year from the date of the index procedure
- Patients will be excluded from the study if they never receive a Biodesign Hernia Graft during their index procedure.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hernia recurrence
Time Frame: 1-year
|
Hernia recurrence through 1-year follow-up
|
1-year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Device-, procedure-, and hernia-related adverse event rates
Time Frame: 2-year
|
Summarize the adverse event rates for normal commercial use of the device (e.g., seroma and infection rates)
|
2-year
|
Hernia recurrence rate through 2-year follow-up
Time Frame: 2-year
|
Assess the long-term success of the device in the reinforcement of hernia repairs through 2-year follow-up
|
2-year
|
Operative times
Time Frame: 2-year
|
What was the operation time for the ventral hernia repair?
|
2-year
|
Hospital stay
Time Frame: 2-year
|
Duration of hospital stay
|
2-year
|
Hospitalization times for related Serious Adverse Events (SAEs)
Time Frame: 2-year
|
What was the hospitalization times for any related SAEs?
|
2-year
|
Patient-reported quality of life: questionaire
Time Frame: 2-year
|
Patient-reported quality of life assessed by completion of a questionaire
|
2-year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-004
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventral Hernia
-
Varazdin General HospitalCompletedIncisional Ventral Hernia | Recurrent Ventral HerniaCroatia
-
Anne Arundel Health System Research InstituteMedtronic - MITGCompletedGrade I Ventral Hernia | Grade II Ventral HerniaUnited States
-
Sofregen Medical, Inc.TerminatedVentral Hernia RepairUnited States
-
University Hospital, Strasbourg, FranceRecruitingVentral Hernia RepairFrance
-
Makassed General HospitalSuspended
-
Zaza DemetrashviliRecruitingLarge Midline Ventral HerniaGeorgia
-
Hvidovre University HospitalUniversity of CopenhagenCompleted
-
Hvidovre University HospitalCopenhagen University Hospital at HerlevCompleted
-
Universitaire Ziekenhuizen KU LeuvenBelgian Section for Abdominal Wall Surgery, section of the Royal Belgian...Not yet recruitingVentral Incisional Hernia
-
University of PennsylvaniaCompleted
Clinical Trials on Biodesign Hernia Graft
-
Icahn School of Medicine at Mount SinaiCompletedVentral Incisional HerniaUnited States
-
Cook Research IncorporatedRecruiting
-
Massarat ZutshiCook Group IncorporatedTerminatedFecal Incontinence | Anal IncontinenceUnited States
-
Ascension South East MichiganWithdrawn
-
University of Alabama at BirminghamStanford University; Cook Group IncorporatedCompletedNasal Septum Perforation
-
Ascension South East MichiganWithdrawnOtologic DiseaseUnited States
-
Karolinska InstitutetUnknownPostoperative Pain | Ventral HerniaSweden
-
Stony Brook UniversityUnknown
-
University of AarhusCook Biotech IncorporatedCompletedPelvic Cancer | Incisional HerniaDenmark
-
Cook Group IncorporatedCompletedVesico-vaginal FistulaUganda